Clinical Significance of MRI Contrast Enhancement of the Oculomotor Nerve in Ischemic Isolated Oculomotor Nerve Palsy
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose Contrast enhancement of the oculomotor nerve in MRI was recently noticed in patients with clinical ischemic isolated oculomotor nerve palsy (iIONP). The opinions about whether this is a sign of inflammation and whether or not to administer steroids vary between doctors. The study aimed to determine the associations between this enhancement and vascular-disease risk factors (VRFs) and inflammatory factors in iIONP patients. Methods The study recruited patients who had experienced iIONP during the previous 2 years. They were divided into groups A and B based on whether or not they exhibited an enhanced oculomotor nerve in MRI of the cavernous sinus using thin-section, fat-suppressed, and contrast-enhanced sequences. VRFs, inflammatory factors, and improvement scores were compared between the two groups. Results Most (71.1%) of the 45 included iIONP patients had enhanced oculomotor nerves in MRI. VRFs, periorbital pain, elevated C-reactive protein and erythrocyte sedimentation rate, the neutrophil-to-lymphocyte ratio, and the platelet-to-lymphocyte ratio were not significantly associated with the enhancement. Four of the five patients in group A exhibited an elevated cerebrospinal fluid (CSF) IgG synthesis rate. The improvement score of eight patients who received 80 mg of methylprednisolone in addition to the routine therapy was not significantly different from the scores of the other patients (p=0.485). Conclusions More than half of the iIONP patients had an enhanced oculomotor nerve in MRI. A few of them also had elevated CSF IgG synthesis rate, but no further evidence for inflammation was found. The administration of steroids seemed to have no benefit other than increasing the blood glucose level.
Abstract
Background and Purpose Contrast enhancement of the oculomotor nerve in MRI was recently noticed in patients with clinical ischemic isolated oculomotor nerve palsy (iIONP). The opinions about whether this is a sign of inflammation and whether or not to administer steroids vary between doctors. The study aimed to determine the associations between this enhancement and vascular-disease risk factors (VRFs) and inflammatory factors in iIONP patients. Methods The study recruited patients who had experienced iIONP during the previous 2 years. They were divided into groups A and B based on whether or not they exhibited an enhanced oculomotor nerve in MRI of the cavernous sinus using thin-section, fat-suppressed, and contrast-enhanced sequences. VRFs, inflammatory factors, and improvement scores were compared between the two groups. Results Most (71.1%) of the 45 included iIONP patients had enhanced oculomotor nerves in MRI. VRFs, periorbital pain, elevated C-reactive protein and erythrocyte sedimentation rate, the neutrophil-to-lymphocyte ratio, and the platelet-to-lymphocyte ratio were not significantly associated with the enhancement. Four of the five patients in group A exhibited an elevated cerebrospinal fluid (CSF) IgG synthesis rate. The improvement score of eight patients who received 80 mg of methylprednisolone in addition to the routine therapy was not significantly different from the scores of the other patients (p=0.485). Conclusions More than half of the iIONP patients had an enhanced oculomotor nerve in MRI. A few of them also had elevated CSF IgG synthesis rate, but no further evidence for inflammation was found. The administration of steroids seemed to have no benefit other than increasing the blood glucose level.
참고문헌 (31)
- 최광동, "Acquired Ocular Motor Nerve Palsy in Neurology Clinics: A Prospective Multicenter Study", Journal of Clinical Neurology, 15(2), pp.221~227 (2019), 대한신경과학회[DOI]
- Tamhankar MA, "Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes : a prospective study", Ophthalmology, 120, pp.2264~2269 (2013)
- Richards BW, "Causes and prognosis in 4, 278cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves", Am J Ophthalmol, 113, pp.489~496 (1992)
- Pineles SL, "Isolated ocular motor nerve palsies", J Binocul Vis Ocul Motil, 68, pp.70~77 (2018)
- Kung NH, "Isolated ocular motor nerve palsies", Semin Neurol, 35, pp.539~548 (2015)
- Chou KL, "Acute ocular motor mononeuropathies : prospective study of the roles of neuroimaging and clinical assessment", J Neurol Sci, 219, pp.35~39 (2004)
- Tamhankar MA, "Management of acute cranial nerve 3, 4and 6 palsies : role of neuroimaging", Curr Opin Ophthalmol, 26, pp.464~468 (2015)
- Murchison AP, "Neuroimaging and acute ocular motor mononeuropathies : a prospective study", Arch Ophthalmol, 129, pp.301~305 (2011)
- Mahalingam HV, "Imaging spectrum of cavernous sinus lesions with histopathologic correlation", Radiographics, 39, pp.795~819 (2019)
- Zhou LY, "Validity and reliability of the Ocular Motor Nerve Palsy Scale", Neural Regen Res, 13, pp.1851~1856 (2018)
- Weber RB, "Pathology of oculomotor nerve palsy in diabetics", Neurology, 20, pp.835~838 (1970)
- Dreyfus PM, "Diabetic ophthalmoplegia; report of case, with postmortem study and comments on vascular supply of human oculomotor nerve", AMA Arch Neurol Psychiatry, 77, pp.337~349 (1957)
- Asbury AK, "Oculomotor palsy in diabetes mellitus : a clinico-pathological study", Brain, 93, pp.555~566 (1970)
- Laughlin RS, "Diabetic radiculoplexus neuropathies", Handb Clin Neurol, 126, pp.45~52 (2014)
- Greenberg JS, "Evaluation and rehabilitation of a patient with diabetic lumbosacral radiculoplexus neuropathy", PM R, 1, pp.774~777 (2009)
- McCormack EP, "Use of MRI in diabetic lumbosacral radiculoplexus neuropathy: case report and review of the literature", Acta Neurochir (Wien), 160, pp.2225~2227 (2018)
- López Ruiz R, "Diabetic lumbosacral radiculoplexus neuropathy succesfully treated with in-travenous immunoglobulins", Med Clin (Barc), 150, pp.452~453 (2018)
- Balta S, "The relation between atherosclerosis and the neutrophil-lymphocyte ratio", Clin Appl Thromb Hemost, 22, pp.405~411 (2016)
- Xu T, "The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus", Medicine (Baltimore), 96, pp.e8289~ (2017)
- Inanc M, "Could platelet indices and neutrophil to lymphocyte ratio be new biomarkers for differentiation of arteritic anterior ischemic neuropathy from non-arteritic type?", Neuroophthalmology, 42, pp.287~294 (2018)
- Koseoglu HI, "Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome", J Thromb Thrombolysis, 39, pp.179~185 (2015)
- Hammad M, "Neutrophil", lymphocyte ratio and platelet, Clin Rheumatol, pp.2018, 37[DOI]
- Pergialiotis V, "Platelet to lymphocyte and neutrophil to lymphocyte ratio as predictive indices of endometrial carcinoma: findings from a retrospective series of patients and meta-analysis", J Gynecol Obstet Hum Reprod, 47, pp.511~516 (2018)
- Azab B, "Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study)", Ren Fail, 34, pp.571~576 (2012)
- Zhou J, "Inflammation : therapeutic targets for diabetic neuropathy", Mol Neurobiol, 49, pp.536~546 (2014)
- Pop-Busui R, "Inflammation as a therapeutic target for diabetic neuropathies", Curr Diab Rep, 16, pp.29~ (2016)
- Zhu Y, "Research progress on the relationship between atherosclerosis and inflammation", Biomolecules, 8, pp.80~ (2018)
- "Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition", Cephalalgia, 38, pp.1~211 (2018)
- Hamada K, "Recurrent painful ophthalmoplegia in a patient with diabetes mellitus : is ophthalmoplegia associated with diabetes mellitus?", Cephalalgia, 36, pp.1397~1398 (2016)
- Mullen E, "Tolosa-Hunt syndrome : appraising the ICHD-3 beta diagnostic criteria", Cephalalgia, 38, pp.1696~1700 (2018)
- Lueck CJ, "Time to retire the Tolosa-Hunt syndrome?", Pract Neurol, 18, pp.350~351 (2018)